Clinical Trials Logo

Metastatic Cancer Pancreas clinical trials

View clinical trials related to Metastatic Cancer Pancreas.

Filter by:
  • None
  • Page 1

NCT ID: NCT02109445 Terminated - Clinical trials for Metastatic Cancer Pancreas

Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer Therapies

Start date: September 3, 2014
Phase: Phase 2
Study type: Interventional

This study consists of a Phase 1b portion aimed to determine the maximum tolerated dose and the safety profile of PF-03084014 in combination with gemcitabine and nab-paclitaxel followed by a Phase 2 portion to evaluate the efficacy of the triple combination in terms of overall survival in patients with metastatic pancreatic ductal adenocarcinoma not previously treated with anticancer therapies.